Our Team has advised Berlin based life science start-up on its extended pre-Series A financing round.
The company received EUR 2 million from the investor GPS Ventures.
BIOMES uses state-of-the-art biotechnological methods to examine bacteria that live in and on the human body. The intestinal flora self-test – which was released as the first product 2018 - is now being marketed and sold internationally. During the pandemic year 2020, BIOMES also demonstrated the flexibility of its proprietary technology platform. Within a very short time, the start-up set up a COVID-19 test track which has already been used to process thousands of corona samples from Berlin und Brandenburg.
BIOMES has been advised by André Eggert and Sohrab Beheshtipour (both Venture Capital).
.jpg){kind=logo}
.png)
.png){kind=logo}
-1673520616.png){kind=logo}
